Published in Eur J Clin Pharmacol on November 10, 2009
A comprehensive review of the pharmacodynamics, pharmacokinetics, and clinical effects of the neutral endopeptidase inhibitor racecadotril. Front Pharmacol (2012) 0.91
Off-label prescribing patterns of antiemetics in children: a multicenter study in Italy. Eur J Pediatr (2012) 0.89
Safety and efficacy of generic drugs with respect to brand formulation. J Pharmacol Pharmacother (2013) 0.82
Effects of glucocorticoids and tumor necrosis factor-alpha inhibitors on both clinical and molecular parameters in patients with Takayasu arteritis. J Pharmacol Pharmacother (2014) 0.80
Skin rash during treatment with generic itraconazole. J Pharmacol Pharmacother (2014) 0.80
Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients. Drug Des Devel Ther (2016) 0.79
Remarks and questions on the article "Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes". Eur J Clin Pharmacol (2010) 0.75
Effects of Racecadotril on Weight Loss and Diarrhea Due to Human Rotavirus in Neonatal Gnotobiotic Pigs (Sus scrofa domesticus). Comp Med (2017) 0.75
A Comprehensive Comparison of the Efficacy and Tolerability of Racecadotril with Other Treatments of Acute Diarrhea in Adults. Front Med (Lausanne) (2016) 0.75
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ (2004) 21.39
The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ (2003) 11.82
Sensor, a population-based cohort study on gastroenteritis in the Netherlands: incidence and etiology. Am J Epidemiol (2001) 6.19
Bacterial and protozoal gastroenteritis. N Engl J Med (1991) 4.40
Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci (2002) 3.98
Viral gastroenteritis. N Engl J Med (1991) 2.58
General outbreaks of infectious intestinal disease in England and Wales: 1995 and 1996. Commun Dis Public Health (1998) 2.35
Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis. Clin Infect Dis (2008) 2.28
"Norwalk-like viruses". Public health consequences and outbreak management. MMWR Recomm Rep (2001) 2.18
Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ (2009) 2.10
Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis (2002) 1.64
The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol (2008) 1.56
Widespread environmental contamination with Norwalk-like viruses (NLV) detected in a prolonged hotel outbreak of gastroenteritis. Epidemiol Infect (2000) 1.41
Racecadotril in the treatment of acute watery diarrhea in children. N Engl J Med (2000) 1.38
Mechanism of the antidiarrheal effect of loperamide. Gastroenterology (1984) 1.33
Viral etiology and incidence associated with acute gastroenteritis in a 5-year survey in Gyeonggi province, South Korea. J Clin Virol (2009) 1.19
Healthcare epidemiology: gastrointestinal flu: norovirus in health care and long-term care facilities. Clin Infect Dis (2008) 1.10
Adverse drug reactions to antibiotics observed in two pulmonology divisions of catanzaro, Italy: a six-year retrospective study. Pharmacol Res (2002) 1.08
Retrospective analysis of adverse drug reactions to bronchodilators observed in two pulmonary divisions of Catanzaro, Italy. Pharmacol Res (2003) 1.07
Approach to acute diarrhea in the elderly. Gastroenterol Clin North Am (1993) 1.05
Acute diarrhea: a practical review. Am J Med (1999) 1.04
A blind, randomized comparison of racecadotril and loperamide for stopping acute diarrhea in adults. World J Gastroenterol (2005) 1.04
Mortality due to gastroenteritis of unknown etiology in the United States. J Infect Dis (2003) 1.02
Retrospective evaluation of adverse drug reactions induced by nonsteroidal anti-inflammatory drugs. Clin Drug Investig (2007) 0.99
Diarrheal diseases in the elderly. Clin Geriatr Med (2007) 0.98
Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine. Br J Pharmacol (2002) 0.96
What's new in enteric infectious diseases at home and abroad. Curr Opin Infect Dis (2005) 0.96
Incidence and genetic diversity of group C rotavirus among adults. J Infect Dis (2000) 0.94
Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor. J Pharmacol Exp Ther (1986) 0.94
A multinational comparison of racecadotril and loperamide in the treatment of acute watery diarrhoea in adults. Scand J Gastroenterol (2002) 0.94
Infectious diarrhea in the elderly. Gastroenterol Clin North Am (2001) 0.93
Transmission of a small round structured virus by vomiting during a hospital outbreak of gastroenteritis. J Hosp Infect (1994) 0.93
Epidemiology of rotavirus-associated hospital admissions in the province of Ferrara, Italy. Eur J Pediatr (2009) 0.90
Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation. J Pharmacol Exp Ther (1989) 0.90
Comparison of racecadotril and loperamide in adults with acute diarrhoea. Aliment Pharmacol Ther (1999) 0.90
Retrospective analysis of adverse drug reactions induced by gemcitabine treatment in patients with non-small cell lung cancer. Pharmacol Res (2004) 0.89
Human intestinal motor activity and transport: effects of a synthetic opiate. Gastroenterology (1986) 0.89
Oral naloxone antagonizes loperamide-induced delay of orocecal transit. Dig Dis Sci (1987) 0.88
Racecadotril versus placebo in the treatment of acute diarrhoea in adults. Aliment Pharmacol Ther (1999) 0.87
The enkephalinase inhibitor, acetorphan, in acute diarrhoea. A double-blind, controlled clinical trial versus loperamide. Scand J Gastroenterol (1993) 0.86
Effect of lidamidine hydrochloride and loperamide on gastric emptying and transit of the small intestine. A double-blind study. Gastroenterology (1986) 0.85
Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvement. Clin Pharmacol Ther (2001) 0.83
Metabolites of loperamide in rats. Biomed Mass Spectrom (1979) 0.82
Racecadotril versus loperamide: antidiarrheal research revisited. Dig Dis Sci (2003) 0.81
Identification of cytochrome P450 isoforms involved in the metabolism of loperamide in human liver microsomes. Eur J Clin Pharmacol (2004) 0.81
Effect of opiates on human colonic adenylate cyclase activity. Eur J Pharmacol (1983) 0.80
Effects of acetorphan, an antidiarrhoeal enkephalinase inhibitor, on oro-caecal and colonic transit times in healthy volunteers. Aliment Pharmacol Ther (1992) 0.80
Report of a rotavirus outbreak in an adult nursing home population. J Am Med Dir Assoc (2003) 0.79
Quantitation of loperamide and N-demethyl-loperamide in human plasma using electrospray ionization with selected reaction ion monitoring liquid chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl (2000) 0.79
Disposition and metabolism of [14C]loperamide in rats. Eur J Drug Metab Pharmacokinet (1979) 0.78
Role of CYP3A5 in abnormal clearance of methadone. Ann Pharmacother (2008) 0.78
Pharmacotherapeutics in older adults. J Wound Ostomy Continence Nurs (2006) 0.75
Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet (2009) 3.82
Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet (2008) 3.36
Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol (2006) 2.24
ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr (2014) 1.78
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics. Am J Gastroenterol (2010) 1.74
Hepatitis C virus infection in an endemic area of Southern Italy 14 years later: evidence for a vanishing infection. Dig Liver Dis (2012) 1.55
Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr (2012) 1.52
Small intestine contrast ultrasonography in pediatric Crohn's disease. J Pediatr (2013) 1.49
Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis. J Res Med Sci (2012) 1.47
A child with aphthae and diarrhoea. Lancet (2002) 1.45
Use of Placebo in Pediatric Inflammatory Bowel Diseases: A Position Paper From ESPGHAN, ECCO, PIBDnet, and the Canadian Children IBD Network. J Pediatr Gastroenterol Nutr (2016) 1.39
Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease. Inflamm Bowel Dis (2007) 1.23
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia (2011) 1.20
Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol (2011) 1.16
Adverse effects of atypical antipsychotics in the elderly: a review. Drugs Aging (2006) 1.15
A distinctive 'microbial signature' in celiac pediatric patients. BMC Microbiol (2010) 1.14
Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Eur J Pharmacol (2003) 1.13
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy. Epilepsia (2009) 1.11
Novel potent anticonvulsant agent containing a tetrahydroisoquinoline skeleton. J Med Chem (2006) 1.06
Higher prevalence and abundance of Bdellovibrio bacteriovorus in the human gut of healthy subjects. PLoS One (2013) 1.06
The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol (2009) 1.04
The discovery of the potent aurora inhibitor MK-0457 (VX-680). Bioorg Med Chem Lett (2009) 1.04
Mast cell positivity to tryptase correlates with metastatic lymph nodes in gastrointestinal cancer patients treated surgically. Oncology (2013) 1.03
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancer. Oncotarget (2013) 1.03
Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. Phytother Res (2013) 1.03
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy. Neuropharmacology (2012) 1.03
Anticonvulsant effects of carbenoxolone in genetically epilepsy prone rats (GEPRs). Neuropharmacology (2004) 1.01
Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy. World J Gastroenterol (2008) 1.01
Pediatric onset Crohn's colitis is characterized by genotype-dependent age-related susceptibility. Inflamm Bowel Dis (2007) 1.01
Hepatotoxicity induced by methimazole in a previously healthy patient. Curr Drug Saf (2009) 0.99
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia (2010) 0.99
Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis (2011) 0.99
Novel anti-ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors. J Cell Physiol (2012) 0.98
Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease. Am J Gastroenterol (2011) 0.97
Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis. Adv Pharmacol Sci (2013) 0.96
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice). Neuropharmacology (2005) 0.96
Evolution of gastric electrical features and gastric emptying in children with Duchenne and Becker muscular dystrophy. Am J Gastroenterol (2005) 0.96
The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis. Mol Neurobiol (2012) 0.95
Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease. Inflamm Bowel Dis (2010) 0.95
Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease. Inflamm Bowel Dis (2009) 0.94
Current status of MR imaging in the evaluation of IBD in a pediatric population of patients. Eur J Radiol (2009) 0.94
Premature subclinical atherosclerosis in pediatric inflammatory bowel disease. J Pediatr (2012) 0.94
MR enterography versus capsule endoscopy in paediatric patients with suspected Crohn's disease. Eur Radiol (2010) 0.93
Lack of efficacy during the switch from brand to generic allopurinol. J Forensic Leg Med (2013) 0.92
Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention. Updates Surg (2012) 0.92
In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder. Blood (2010) 0.92
Intralesional steroid injection after endoscopic balloon dilation in pediatric Crohn's disease with stricture: a prospective, randomized, double-blind, controlled trial. Gastrointest Endosc (2010) 0.92
Retracted Gut microbiota and pediatric disease. Dig Dis (2011) 0.92
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model. Epilepsia (2011) 0.91
mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy. Neuropharmacology (2012) 0.91
The infant gastroesophageal reflux questionnaire revised: development and validation as an evaluative instrument. Clin Gastroenterol Hepatol (2006) 0.91
Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease. Infect Immun (2012) 0.90
Gluten-free sourdough wheat baked goods appear safe for young celiac patients: a pilot study. J Pediatr Gastroenterol Nutr (2010) 0.89
Dominant genotypes in mucosa-associated Escherichia coli strains from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis (2009) 0.89
Asterixis as a presentation of cerebellar ischemic stroke. West J Emerg Med (2012) 0.88
Use and safety of antipsychotics in behavioral disorders in elderly people with dementia. J Clin Psychopharmacol (2014) 0.88
Solution-phase parallel synthesis of novel 1,2,3,4-tetrahydroisoquinoline-1-ones as anticonvulsant agents. Chem Pharm Bull (Tokyo) (2008) 0.88
Phenotype and disease course of early-onset pediatric inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.88
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.87
Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice. Eur J Pharmacol (2004) 0.87
Venlafaxine-propafenone interaction resulting in hallucinations and psychomotor agitation. Ann Pharmacother (2008) 0.87
Cerebral stroke injury: the role of cytokines and brain inflammation. J Basic Clin Physiol Pharmacol (2014) 0.86
Phenobarbital/Lamotrigine coadministration-induced blood dyscrasia in a patient with epilepsy. Ann Pharmacother (2010) 0.86
Enteric neuropathology of congenital intestinal obstruction: A case report. World J Gastroenterol (2006) 0.86
Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial. Helicobacter (2004) 0.86
Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study. Medicine (Baltimore) (2016) 0.86
Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease. Inflamm Bowel Dis (2012) 0.86
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. Eur J Neurosci (2009) 0.85
Rosacea-like facial rash related to metformin administration in a young woman. BMC Pharmacol Toxicol (2014) 0.85
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity. Neuropharmacology (2012) 0.85
Mucosal NOD2 expression and NF-kappaB activation in pediatric Crohn's disease. Inflamm Bowel Dis (2008) 0.85
Effects of disease activity on anti-Saccharomyces cerevisiae antibodies: implications for diagnosis and follow-up of children with Crohn's disease. Inflamm Bowel Dis (2004) 0.85
Anticonvulsant profile of flunarizine and relation to Na(+) channel blocking effects. Basic Clin Pharmacol Toxicol (2004) 0.85
Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis (2013) 0.85
Analysis of candidate genes on chromosomes 5q and 19p in celiac disease. J Pediatr Gastroenterol Nutr (2007) 0.84
Efficacy and safety of off-label use of fondaparinux in the management of heparin-induced thrombocytopenia with thrombosis in an elderly woman. J Clin Pharmacol (2013) 0.84
Tacrolimus and food allergy. Transplantation (2003) 0.84
A potential role of Escherichia coli pathobionts in the pathogenesis of pediatric inflammatory bowel disease. Can J Microbiol (2012) 0.84
Neuropharmacology of depression in aging and age-related diseases. Ageing Res Rev (2002) 0.84
Usefulness of single-balloon enteroscopy in pediatric Crohn's disease. Gastrointest Endosc (2012) 0.84
Spinal myoclonus responsive to topiramate. Mov Disord (2004) 0.84
Detection of Crohn disease lesions of the small and large bowel in pediatric patients: diagnostic value of MR enterography versus reference examinations. AJR Am J Roentgenol (2014) 0.83
Chronic granulomatous disease mimicking early-onset Crohn's disease with cutaneous manifestations. BMC Pediatr (2014) 0.83
Effects of ethanol on the development of genetically determined epilepsies in rats. Int J Dev Neurosci (2008) 0.83
A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman. Curr Drug Saf (2009) 0.83
Polyomavirus JC reactivation and noncoding control region sequence analysis in pediatric Crohn's disease patients treated with infliximab. J Neurovirol (2011) 0.83
Use of topiramate for glossodynia. Pain Med (2007) 0.83
Effects of acetaminophen and ibuprofen in children with migraine receiving preventive treatment with magnesium. Headache (2013) 0.83
Efficacy of adalimumab in moderate-to-severe pediatric Crohn's disease. Am J Gastroenterol (2009) 0.83
Nitric oxide production in rectal dialysate is a marker of disease activity and location in children with inflammatory bowel disease. Am J Gastroenterol (2002) 0.83
Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice. Pharmacol Res (2012) 0.83
A pediatric non-protein losing Menetrier's disease successfully treated with octreotide long acting release. World J Gastroenterol (2012) 0.82
Allergic proctocolitis refractory to maternal hypoallergenic diet in exclusively breast-fed infants: a clinical observation. BMC Gastroenterol (2011) 0.82
Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma. Hum Gene Ther (2013) 0.82
Pneumatic balloon dilation in pediatric achalasia: efficacy and factors predicting outcome at a single tertiary pediatric gastroenterology center. Gastrointest Endosc (2012) 0.82
Role of gastroesophageal reflux in children with unexplained chronic cough. J Pediatr Gastroenterol Nutr (2011) 0.82
Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids. J Med Chem (2003) 0.81
A comprehensive safety evaluation of trabectedin and drug-drug interactions of trabectedin-based combinations. BioDrugs (2014) 0.81